ETF收评 | 创新药板块逆势爆发！科创创新药ETF汇添富、科创创新药ETF国泰飙涨超7%

Market Overview - The A-share market experienced a broad decline, with the Shanghai Composite Index falling by 0.81%, accumulating a 1.85% increase in October and briefly surpassing 4000 points [1] - The Shenzhen Component dropped by 1.14%, with a cumulative decline of 1.1% in October [1] - The ChiNext Index decreased by 2.31%, accumulating a 1.56% decline in October [1] Trading Volume - The total trading volume in the Shanghai, Shenzhen, and Beijing markets was 23,498 billion yuan, a decrease of 1,145 billion yuan compared to the previous day [1] Sector Performance - Over 3,700 stocks rose against the market trend, while the computing hardware industry chain saw a significant pullback, particularly in CPO and memory sectors [1] - The semiconductor, consumer electronics, and rare earth sectors experienced notable declines [1] - AI applications, innovative pharmaceuticals, and large consumer concept stocks showed resilience and performed well [1] ETF Performance - The innovative pharmaceutical sector saw a comprehensive rebound, with the ETF for innovative pharmaceuticals from Huatai-PineBridge and Guotai rising by 7.71% and 7.27%, respectively [1] - Hong Kong's innovative pharmaceutical ETFs also followed suit, with gains exceeding 5% for several funds [1] - The Nikkei 225 index rose by 2.12%, reaching a new historical high, with related ETFs from E Fund and Huaan increasing by 3.39% and 2.94%, respectively [1] Declines in Specific Sectors - The AI hardware sector faced significant setbacks, with communication ETFs and communication equipment ETFs both declining by over 5% [1] - The semiconductor sector also weakened, with semiconductor equipment ETFs from E Fund and the Sci-Tech semiconductor ETF both dropping by 4% [1]